Syncom Formulations (India) Limited Cash Flow Conversion Efficiency
Syncom Formulations (India) Limited cash flow conversion efficiency. Based on the latest financial reports, Syncom Formulations (India) Limited (SYNCOMF) has a cash flow conversion efficiency ratio of 0.007x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs17.58 Million ≈ $190.08K USD) by net assets (Rs2.70 Billion ≈ $29.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Syncom Formulations (India) Limited (2006–2025)
Cash flow conversion efficiency of Syncom Formulations (India) Limited from 2006 to 2025. This chart illustrates how Syncom Formulations (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SYNCOMF stock price for real-time trading data and today's change.
Syncom Formulations (India) Limited Cash Flow Conversion Ratio Explained
Syncom Formulations (India) Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Syncom Formulations (India) Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Syncom Formulations (India) Limited ranked by their cash flow conversion efficiency. Also see market cap of Syncom Formulations (India) Limited for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kross Ltd
NSE:KROSS
|
0.010x |
|
Uxin Ltd
NASDAQ:UXIN
|
-2.472x |
|
Site Centers Corp
NYSE:SITC
|
-0.013x |
|
Arise Windpower AB
ST:ARISE
|
0.147x |
|
Henan BCCY Environmental Energy Co. Ltd
SHE:300614
|
N/A |
|
D2L Inc
TO:DTOL
|
0.402x |
|
Vef AB
ST:VEFAB
|
-0.001x |
|
Embention Sistemas Inteligentes S.A.
PA:MLUAV
|
N/A |
Annual Cash Flow Conversion Efficiency for Syncom Formulations (India) Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Syncom Formulations (India) Limited from 2006 to 2025. Review Syncom Formulations (India) Limited (SYNCOMF) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs3.42 Billion ≈ $37.00 Million |
Rs234.36 Million ≈ $2.53 Million |
0.068x | +430.29% |
| 2024-03-31 | Rs2.87 Billion ≈ $31.07 Million |
Rs-59.58 Million ≈ $-644.37K |
-0.021x | -150.42% |
| 2023-03-31 | Rs2.56 Billion ≈ $27.69 Million |
Rs105.29 Million ≈ $1.14 Million |
0.041x | -44.03% |
| 2022-03-31 | Rs2.22 Billion ≈ $24.03 Million |
Rs163.29 Million ≈ $1.77 Million |
0.073x | +791.44% |
| 2021-03-31 | Rs1.88 Billion ≈ $20.29 Million |
Rs-19.93 Million ≈ $-215.59K |
-0.011x | -206.10% |
| 2020-03-31 | Rs1.46 Billion ≈ $15.75 Million |
Rs-5.06 Million ≈ $-54.69K |
-0.003x | -110.64% |
| 2019-03-31 | Rs1.33 Billion ≈ $14.34 Million |
Rs43.29 Million ≈ $468.17K |
0.033x | +348.68% |
| 2018-03-31 | Rs1.22 Billion ≈ $13.19 Million |
Rs-16.01 Million ≈ $-173.10K |
-0.013x | -111.13% |
| 2017-03-31 | Rs1.17 Billion ≈ $12.69 Million |
Rs138.41 Million ≈ $1.50 Million |
0.118x | -46.97% |
| 2016-03-31 | Rs1.09 Billion ≈ $11.76 Million |
Rs241.74 Million ≈ $2.61 Million |
0.222x | +11832.06% |
| 2015-03-31 | Rs1.00 Billion ≈ $10.84 Million |
Rs1.87 Million ≈ $20.20K |
0.002x | -97.36% |
| 2014-03-31 | Rs951.99 Million ≈ $10.30 Million |
Rs67.30 Million ≈ $727.87K |
0.071x | +7.30% |
| 2013-03-31 | Rs877.09 Million ≈ $9.49 Million |
Rs57.79 Million ≈ $624.96K |
0.066x | -14.20% |
| 2012-03-31 | Rs836.08 Million ≈ $9.04 Million |
Rs64.20 Million ≈ $694.33K |
0.077x | +281.55% |
| 2011-03-31 | Rs816.58 Million ≈ $8.83 Million |
Rs-34.54 Million ≈ $-373.52K |
-0.042x | -381.24% |
| 2010-03-31 | Rs550.47 Million ≈ $5.95 Million |
Rs-4.84 Million ≈ $-52.32K |
-0.009x | +51.59% |
| 2009-03-31 | Rs411.32 Million ≈ $4.45 Million |
Rs-7.47 Million ≈ $-80.76K |
-0.018x | -112.90% |
| 2008-03-31 | Rs390.34 Million ≈ $4.22 Million |
Rs54.94 Million ≈ $594.11K |
0.141x | -0.43% |
| 2007-03-31 | Rs342.37 Million ≈ $3.70 Million |
Rs48.40 Million ≈ $523.37K |
0.141x | +69.71% |
| 2006-03-31 | Rs292.59 Million ≈ $3.16 Million |
Rs24.37 Million ≈ $263.55K |
0.083x | -- |
About Syncom Formulations (India) Limited
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and su… Read more